Email

NIH/NIAID) [E] [ay ndences ay ) LAM [AID DEA DART VIH/NIAID) [--] i (NIH/NIAID) [E] NIAID) [E] > AID DIR-OCGR in )) i P| >; Billet, ?; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: URGENT ACTION by 10am Monday 7/15: Review draft NIAID TA on Risky Research Review Act Importance: High Hello all, Background Thank you very much for your quick work to comment on the Risky Research Review Act. NIH OLPA has asked us to prioritize comments to flag the most urgent or concerning items and/or those needing clarification. Action Item We have compiled the comments that meet NIH OLPA's request into the attached draft technical assistance document. Please note that NIH OLPA has requested examples, where possible. We have tried to add some examples to emphasize key points, but we welcome any suggestions and/or corrections as needed. We would appreciate your review and any edits by 10am Monday, July 15th. Given the quick turnaround, we are asking the Divisions to review concurrently with the NIAID OD. Please note that NIH OSP, NIH ORS/DOHS, and NIH OER will also be reviewing and providing comments. We will be sure to share with you any consolidated NIH comments that we receive. Thank you for your help with this quick turnaround request. Please let me know if you have any questions. Thanks, Sara